Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP422112.RAyGIx1VGeRIoT3sIN_lNiw2RAeMhRJqzjquX67yFKK9Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP422112.RAyGIx1VGeRIoT3sIN_lNiw2RAeMhRJqzjquX67yFKK9Y130_assertion type Assertion NP422112.RAyGIx1VGeRIoT3sIN_lNiw2RAeMhRJqzjquX67yFKK9Y130_head.
- NP422112.RAyGIx1VGeRIoT3sIN_lNiw2RAeMhRJqzjquX67yFKK9Y130_assertion description "[We describe the development of the first ELISA for myostatin immunoreactivity and its validation during recompensating therapy for CHF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP422112.RAyGIx1VGeRIoT3sIN_lNiw2RAeMhRJqzjquX67yFKK9Y130_provenance.
- NP422112.RAyGIx1VGeRIoT3sIN_lNiw2RAeMhRJqzjquX67yFKK9Y130_assertion evidence source_evidence_literature NP422112.RAyGIx1VGeRIoT3sIN_lNiw2RAeMhRJqzjquX67yFKK9Y130_provenance.
- NP422112.RAyGIx1VGeRIoT3sIN_lNiw2RAeMhRJqzjquX67yFKK9Y130_assertion SIO_000772 22561185 NP422112.RAyGIx1VGeRIoT3sIN_lNiw2RAeMhRJqzjquX67yFKK9Y130_provenance.
- NP422112.RAyGIx1VGeRIoT3sIN_lNiw2RAeMhRJqzjquX67yFKK9Y130_assertion wasDerivedFrom befree-20150227 NP422112.RAyGIx1VGeRIoT3sIN_lNiw2RAeMhRJqzjquX67yFKK9Y130_provenance.
- NP422112.RAyGIx1VGeRIoT3sIN_lNiw2RAeMhRJqzjquX67yFKK9Y130_assertion wasGeneratedBy ECO_0000203 NP422112.RAyGIx1VGeRIoT3sIN_lNiw2RAeMhRJqzjquX67yFKK9Y130_provenance.